Point72 Asia (Singapore) Pte. Ltd. Bio Xcel Therapeutics, Inc. Transaction History

Point72 Asia (Singapore) Pte. Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.32 - $0.73 $240 - $549	753 Added 4.96%	15,939 $5.96 Million
Q3 2024 Nov 14, 2024	SELL	$0.53 - $1.34 $8,007 - $20,246	-15,109 Reduced 49.87%	15,186 $9.26 Million
Q2 2024 Aug 14, 2024	BUY	$1.14 - $2.97 $34,536 - $89,976	30,295 New	30,295 $38.8 Million

502K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $42.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.